R, M., R, G., DW, C., A, L., J, F., R, R., . . . RB, P. (2007). The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: A randomized controlled clinical trial--AIDS clinical trials group 328. Archives of Internal Medicine, 167(6), 597. https://doi.org/10.1001/archinte.167.6.597
Chicago Style (17th ed.) CitationR, Mitsuyasu, et al. "The Virologic, Immunologic, and Clinical Effects of Interleukin 2 with Potent Antiretroviral Therapy in Patients with Moderately Advanced Human Immunodeficiency Virus Infection: A Randomized Controlled Clinical Trial--AIDS Clinical Trials Group 328." Archives of Internal Medicine 167, no. 6 (2007): 597. https://doi.org/10.1001/archinte.167.6.597.
MLA (9th ed.) CitationR, Mitsuyasu, et al. "The Virologic, Immunologic, and Clinical Effects of Interleukin 2 with Potent Antiretroviral Therapy in Patients with Moderately Advanced Human Immunodeficiency Virus Infection: A Randomized Controlled Clinical Trial--AIDS Clinical Trials Group 328." Archives of Internal Medicine, vol. 167, no. 6, 2007, p. 597, https://doi.org/10.1001/archinte.167.6.597.
